DONATE

Search Results for:

A molecular mechanism could explain how bacteria resist antibiotics

IBEC researchers have shown for the first time how bacteria make DNA under stressful conditions, such as drug treatments.

This new knowledge could help develop new antibiotics that work, tackling the urgent problem of antibiotic resistance.

The Bacterial infections: antimicrobial therapies group led by Dr. Eduard Torrents was studying the bacterial strain Pseudomonas aeruginosa, which can cause severe chronic lung infections in cystic fibrosis (CF) patients, leading to severely impaired lung function, an increased risk of respiratory failure, and death.

Another IBEC winner nets a Premi PIONER

Maria Valls from IBEC’s Biomimetic systems for cell engineering group has won a PIONER prize from CERCA for her doctoral thesis.

She’s the second ever IBEC winner of one of these prestigious prizes, which since their launch in 2014 have recognised theses with results that are clearly aimed at commercial exploitation.

The jury described her thesis, ‘Development of an advanced 3D culture system for human cardiac tissue engineering’, as having “a high degree of complexity and promising results, which combines different disciplines within the field of bioengineering to create a bioreactor”.